Dexcom (DXCM) Notes Payables (2022 - 2025)

Dexcom (DXCM) has reported Notes Payables for 4 consecutive years, with $1.2 billion the latest figure, recorded in Q3 2025.

• On a quarterly basis, Notes Payables changed N/A year-over-year to $1.2 billion in Q3 2025; TTM through Sep 2025 was $1.2 billion, a N/A change from a year earlier, with the FY2024 full-year figure at $1.2 billion, changed N/A from the prior year.
• Notes Payables was $1.2 billion for Q3 2025 at Dexcom, roughly flat from $1.2 billion in the prior quarter.
• Over five years, Notes Payables peaked at $1.2 billion in Q3 2025 and troughed at $124.2 million in Q3 2023.
• A 4-year average of $908.3 million and a median of $989.1 million in 2023 frame the typical range for Notes Payables.